(D’Aunno, Pollack, Frimpong, & Wuchiett, 2014). Similarly, a study in our setting found that 50% of MMT participants received mean daily doses below 60 mg per day (Nosyk et al., 2009). Furthermore, higher MMT dose has been associated with better ART adherence (Lappalainen et al., 2015). These findings underscore the need to support patients and prescribers in targeting optimal MMT dosing to support treatment retention.
